Equally potent? Does cellular reprogramming justify the abandonment of human embryonic stem cells?

Induced pluripotent stem cells and our ability to transdifferentiate somatic cells might obviate the clinical use of embryonic stem cells in the future. Too many questions currently remain unanswered, however, to abandon embryonic stem cell research.

Saved in:
Bibliographic Details
Published inEMBO reports Vol. 13; no. 10; pp. 890 - 894
Main Authors Nazor, Kristopher L, Loring, Jeanne F, Laurent, Louise C
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.10.2012
Springer Nature B.V
Nature Publishing Group
Subjects
Biotechnology
Cellular biology
Cellular Reprogramming
EMBO51
EMBO52
Embryonic Stem Cells
Humans
Medical technology
Pluripotent Stem Cells
Science & Society
Science and Society
Stem Cell Research - economics
Stem Cell Research - ethics
Stem Cell Research - legislation & jurisprudence
Stem cells
Transplants & implants
Online AccessGet full text

Cover

More Information
Summary:Induced pluripotent stem cells and our ability to transdifferentiate somatic cells might obviate the clinical use of embryonic stem cells in the future. Too many questions currently remain unanswered, however, to abandon embryonic stem cell research.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Commentary-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Kristopher L Nazor and Jeanne F Loring [middle] are at the Center for Regenerative Medicine, Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA. Jeanne F Loring also holds an adjunct position at the University of California, San Diego, California, USA. Louise C Laurent is at the University of California, San Diego, Department of Reproductive Medicine, La Jolla, California, USA. E.mail: llaurent@ucsd.edu
ISSN:1469-221X
1469-3178
1469-3178
DOI:10.1038/embor.2012.134